ARTICLE | Clinical News
CHMP backs approval of GSK shingles vaccine Shingrix
February 2, 2018 8:30 PM UTC
EMA’s CHMP recommended approval of Shingrix herpes zoster vaccine (HZ/su, GSK1437173A) from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) for prevention of herpes zoster (shingles) and post-herpetic neuralg...